Schroder Investment Management Group
ALT icon

Schroder Investment Management Group’s Altimmune ALT Stock Holding History

Schroder Investment Management Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-667,837
Closed -$1.92M – 1173
2026
Q1 		$1.92M Buy
667,837
+198,824
+42% +$844K ﹤0.01% 938
2025
Q4 		$1.69M Buy
+469,013
New +$2.04M ﹤0.01% 912
2025
Q2 		– Sell
-961,884
Closed -$5.12M – 1157
2025
Q1 		$5.12M Buy
961,884
+533,563
+125% +$3.38M 0.01% 753
2024
Q4 		$3.14M Sell
428,321
-45,544
-10% -$348K ﹤0.01% 857
2024
Q3 		$3.07M Hold
473,865
– – ﹤0.01% 880
2024
Q2 		$3.15M Buy
473,865
+283,041
+148% +$2.09M ﹤0.01% 869
2024
Q1 		$1.94M Buy
+190,824
New +$1.94M ﹤0.01% 928

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Schroder Investment Management Group's ALT Position: Q2 2026 in Review

Schroder Investment Management Group sold out of Altimmune (ALT) in Q2 2026, closing a stake of 667,837 shares — an estimated $1.92M sold.

Schroder Investment Management Group first reported a position in ALT in Q1 2024 and held it in 7 quarters. The position peaked at $5.12M in Q1 2025. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Schroder Investment Management Group reported no remaining Altimmune position as of Q2 2026 after selling out during the quarter.
  • Schroder Investment Management Group sold 667,837 Altimmune shares in Q2 2026, an estimated $1.92M.
  • Schroder Investment Management Group first reported a position in Altimmune in Q1 2024 and held it in 7 quarters.
  • Schroder Investment Management Group's Altimmune position peaked at $5.12M in Q1 2025.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.